✦ LIBER ✦

Pathologic Complete Response to Preoperative Sequential Doxorubicin/Cyclophosphamide and Single-Agent Taxane With or Without Trastuzumab in Stage II/III HER2-Positive Breast Cancer

✍ Scribed by Saranya Chumsri; Stacie Jeter; Lisa K. Jacobs; Hind Nassar; Deborah K. Armstrong; Leisha A. Emens; John H. Fetting; Julie R. Lange; Carol Riley; Theodore N. Tsangaris; Antonio C. Wolff; Richard Zellars; Zhe Zhang; Vered Stearns

Book ID: 115075852
Publisher: CIG Media Group, LP.
Year: 2010
Tongue: English
Weight: 124 KB
Volume: 10
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2010.n.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of the Addition of Carboplatin an

Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)

✍ Sikov, William M. (author);Berry, Donald A. (author);Perou, Charles M. (author); 📂 Article 📅 2015 🏛 American Society of Clinical Oncology 🌐 English ⚖ 288 KB

Impact of the Addition of Carboplatin an

✍ Sikov, William M. (author);Berry, Donald A. (author);Perou, Charles M. (author); 📂 Article 📅 2015 🏛 American Society of Clinical Oncology 🌐 English ⚖ 288 KB